Atlas Trials

Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients

Clinical trial NCT04935580 · UNKNOWN

Trial details

NCT number
NCT04935580
Sponsor
Shanghai Changzheng Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2021-06-28
Primary completion
2023-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.